ACETO Corp (ACET) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
ACETO Reports Fiscal 2018 First Quarter Results
November 2, 2017 5:00 PM EDTPORT WASHINGTON, N.Y., Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018 ended September 30, 2017.
First Quarter Fiscal 2018 versus First Quarter Fiscal 2017
Net sales of $185.3 million versus $128.0 million, a 44.7% increaseGross profit of $40.0 million versus $30.8 million, a 29.7% increaseNet income of $0.5 million versus $4.4 million, a 89.6% decreaseDiluted EPS of $0.01 versus $0.15, an 93.3% decreaseNon-GAAP Adjusted Net Income of $10.7 million versus $8.3 million, a... More